Market-Moving Exclusives

EXCLUSIVE: Silo Pharma's Investigational Ketamine Implant Hits All Endpoints In Pain Study In Animal Models
EXCLUSIVE: Wix And ActiveCampaign Collaborate To Boost Engagement And Marketing Automation
EXCLUSIVE: SolarBank To Develop 7.2 MW Solar Project In New York
EXCLUSIVE: Wix And ActiveCampaign Collaborate To Boost Engagement And Marketing Automation
EXCLUSIVE: SolarBank To Develop 7.2 MW Solar Project In New York
EXCLUSIVE: Beeline Breaks $1 Billion Barrier, Bets Big On AI And Short-Term Rental Surge
EXCLUSIVE: Artelo Biosciences' New Peer-Reviewed Research Shows Effectiveness Of Psoriasis Candidate In Animal Models

Market-Moving Exclusives Recent News

EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain
NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030.
EXCLUSIVE: Eco Wave Power Marks US Manufacturing Debut With Port Of Los Angeles Project
Eco Wave Power signs manufacturing deal for floaters with All-Ways Metal, Inc in California. Deal accelerates project timelines and supports local job creation.
EXCLUSIVE: Worksport's March B2B Sales Soar Nearly 70%
Worksport Ltd (WKSP) reported strong Q1 gains in B2B sales for their AL4 premium tonneau cover, with a 70% increase in March. US production and partnerships driving growth.
EXCLUSIVE: La Rosa FY24 Revenue Jumps 119%, CEO Reiterates FY25 Topline Goal Of $100 Million
La Rosa Holdings (LRHC) reported strong financial results for 2024, with total revenue increasing by 119% and plans to expand internationally and acquire additional brokerage firms.
EXCLUSIVE: MIRA Pharmaceuticals Ketamir-2 Shows Efficacy In Diabetes-Associated Nerve Damage In Animal Study
MIRA's Ketamir-2 shows promise in treating diabetic neuropathy, with a Phase 2a trial expected by late 2025 and human data in early 2026.
EXCLUSIVE: Vivani Medical Collaborates With Okava To Expand Development Of GLP-1 Therapy For Dogs
Vivani Medical and Okava expand GLP-1 therapy research to dogs, aiming to advance long-acting treatments for cardiometabolic conditions.
EXCLUSIVE: Janover Acquires $4.6 Million Of Solana (SOL), Begins Digital Asset Treasury Strategy
Janover Inc (NASDAQ:JNVR) announced Thursday that it has purchased approximately $4.6 million Solana (CRYPTO: SOL), marking the first execution under its newly adopted
EXCLUSIVE: Capstone Eyes $100 Million Goal With Southeast Expansion, Targets 1,500 Acquisition Opportunities
Capstone Holding Corp announced pursuit of opportunities in Southeast U.S. to accelerate growth through strategic M&A. CEO highlights infrastructure and operational discipline. Stock closed 39% higher.
EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent
Anixa secures USPTO patent for its breast cancer vaccine using α-lactalbumin, enhancing its IP portfolio and expanding future immunotherapy options.
EXCLUSIVE: Capstone Clocks 8% Q4 Revenue Growth, Aims For $100 Million Revenue Run Rate By 2025
Capstone Holding Corp (CAPS) announced its Q4 results with 8% revenue growth, successful launch of Toro Stone, and plans for strategic acquisitions.

Connect With Us

instagramlinkedinyoutube

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2025 Benzinga | All Rights Reserved